本页面由Tiger Trade Technology Pte. Ltd.提供服务

Sunshine Biopharma Inc.

0.2926
-0.0452-13.38%
成交量:130.00万
成交额:38.93万
市值:126.12万
市盈率:-0.03
高:0.3138
开:0.3040
低:0.2824
收:0.3378
52周最高:24.30
52周最低:0.2824
股本:431.03万
流通股本:424.20万
量比:0.13
换手率:30.65%
股息:- -
股息率:- -
每股收益(TTM):-10.0329
每股收益(LYR):-14.3739
净资产收益率:-21.92%
总资产收益率:-9.91%
市净率:0.05
市盈率(LYR):-0.02

数据加载中...

2026/10/09

重要事件披露

Form 8-K - Current report
2026/10/05

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/10/02

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/09/16

重要事件披露

Form 8-K - Current report
2026/09/11

重要事件披露

Form 8-K - Current report
2026/08/28

重要事件披露

Form 8-K - Current report
2026/08/28

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/03

重要事件披露

Form 8-K - Current report
2026/07/20

重要事件披露

Form 8-K - Current report
2026/07/10

重要事件披露

Form 8-K - Current report
2026/07/08

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/29

重要事件披露

Form 8-K - Current report
2026/05/22

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/22

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/20

重要事件披露

Form 8-K - Current report
2026/05/18

SEC问询函

Form CORRESP - Correspondence
2026/05/18

SEC问询函

Form CORRESP - Correspondence